Scientific articles 17 Dec 2025 Kronopolitides A–F, a family of 36-membered polyol macrolides with antiparasitic activity against Chagas disease Journal of Natural Products
In the media 15 Dec 2025 The biggest mosquito-borne disease in the world has a cure. There’s just one problem Vox
News 4 Dec 2025 Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
In the media 2 Dec 2025 “Como si me comiera desde dentro”: la enfermedad que ataca los huesos en el norte de Kenia EFE
Scientific articles 2 Dec 2025 The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities Parasites & Vectors
Press releases 27 Nov 2025 International seminar explores the development of treatments for dengue for populations not covered by vaccines
News 26 Nov 2025 DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment
Scientific articles 25 Nov 2025 Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing Clinical Pharmacology & Therapeutics
Videos 24 Nov 2025 Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair
Scientific articles 20 Nov 2025 Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants British Journal of Clinical Pharmacology
Press releases 15 Apr 2025 New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease
Press releases 18 Mar 2025 DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease
Press releases 13 Feb 2025 DNDi announces organizational strategy update and strengthened executive team
Press releases 10 Feb 2025 The African Union Commission Strengthens Collaboration with the Drugs for Neglected Diseases initiative
Press releases 4 Feb 2025 Hyundai Bio (HDB) and DNDi sign MOU for joint development of Xafty-based dengue treatment
Press releases 30 Jan 2025 DNDi welcomes GHIT support for new collaboration with Eisai for dengue and Zika virus disease
Press releases 30 Jan 2025 IRD, DNDi and Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
